SA PRO
Free Account
Vor Biopharma Inc.VORNASDAQ
LOADING
|||
Switch Symbol:
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 77% recommend buying.

Consensus Rating
Buy
13 analysts·Moderate coverage
77%
Rating Distribution
Strong Buy
00%
Buy
1077%
Hold
323%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Dec 23, 2025Robert W. Baird
Vor Bio price target lowered to $46 from $64 at Baird
Target:$46.00
+235.5%from $13.71
Oct 29, 2025H.C. Wainwright
Vor Bio price target adjusted to $55 at H.C. Wainwright after reverse split
Target:$55.00
+104.3%from $26.93
Oct 14, 2025Robert W. Baird
Vor Bio upgraded to Outperform from Neutral at Baird
Target:$64.00
+107.7%from $30.81
Sep 24, 2025Stifel Nicolaus
Vor Bio upgraded to Buy from Hold at Stifel
Target:$55.00
+75.8%from $31.28
Jun 30, 2025H.C. Wainwright
Vor Bio upgraded to Buy from Neutral at H.C. Wainwright
Target:$3.00
+85.2%from $1.62
Apr 27, 2022Goldman Sachs
Goldman Sachs Initiates Coverage On Vor Biopharma with Neutral Rating, Announces Price Target of $6
Target:$6.00
+7.1%from $5.60

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance